The Impact of Baseline Visual Acuity on the Treatment Outcomes in Patients Treated With AflIbercept in Real-life Clinical Setting

NCT03278262 · clinicaltrials.gov ↗

COMPLETED

Status

2312

Enrollment

INDUSTRY

Sponsor class

Conditions

Wet Macular Degeneration

Interventions

DRUG: Aflibercept (Eylea, BAY86-5321)

Sponsor

Bayer

Collaborators

[object Object]